Resonance HealthASX:RHT +4.55% OCF Yield % is 1.83 as of Jun. 24, 2026, which is 17% above its 10-year median of 1.56. The stock has 6 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Resonance Health ranks worse than 64.38% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Resonance Health's OCF Yield % or its related term are showing as below:
ASX:RHT'
s OCF Yield % Range Over the Past 10 Years
Min: -8.53 Med: 1.56 Max: 8.45
Current: 1.83
During the past 13 years, the highest OCF Yield % of Resonance Health was 8.45%. The lowest was -8.53%. And the median was 1.56%.
ASX:RHT's OCF Yield % is ranked worse than 64.38% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 5.56
vs ASX:RHT: 1.83
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Resonance Health OCF Yield % Related Terms
Resonance Health OCF Yield % Historical Data
* Premium members only.
The historical data trend for Resonance Health's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:RHT vs VEEV, BTSG, TEM: OCF Yield % Comparison
For the Health Information Services subindustry, Resonance Health's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Resonance Health's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health (ASX:RHT) has a OCF Yield % of 1.83 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Resonance Health and its competitors. This is 17% above median its historical median of 1.56. According to the industry distribution chart, Resonance Health ranks #441 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 64.4%.
Is Resonance Health's OCF Yield % too high?
Resonance Health's current OCF Yield % of 1.83 is 17% above median its 10-year median of 1.56. The Healthcare Providers & Services industry median OCF Yield % is 5.56. Resonance Health's value of 1.83 is 67.1% below this industry median. Based on the distribution chart, Resonance Health ranks #441 out of 685 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Resonance Health's OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #441 out of 685 companies for OCF Yield %. This places Resonance Health in the lower half of its industry. The industry median OCF Yield % is 5.56. Resonance Health's value of 1.83 is 67.1% below this benchmark. While the company's 10-year median is 1.56 vs. the industry median of 5.56, Resonance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.56, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Health's current OCF Yield % of 1.83 is 67.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current OCF Yield % is 1.83, which is 17% above median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current OCF Yield % is 1.83, which is 17% above median its 10-year median of 1.56 and 67.1% below the Healthcare Providers & Services industry median of 5.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current OCF Yield % is 1.83 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 